New eye drop shows promise for dry eye sufferers
NCT ID NCT06493604
First seen Jan 11, 2026 · Last updated May 25, 2026 · Updated 18 times
Summary
This study tested a new eye drop called reproxalap (0.25%) in 116 adults with dry eye disease. The goal was to see if it reduces eye discomfort better than a placebo drop. Participants rated their discomfort over 100 minutes in a dry environment. The trial is complete and results will show if reproxalap offers faster or greater symptom relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Andover Eye Associates
Andover, Massachusetts, 01810, United States
Conditions
Explore the condition pages connected to this study.